Open AccessPrevalence of Microalbuminuria in Hypertensive Patients
Author(s) -
Nilesh Gangadhar More,
Priyank Dumade,
Navneet Agrahari,
Madhukar Gaikwad
Publication year - 2018
Publication title -
international journal of innovative research in medical science
Language(s) - English
Resource type - Journals
ISSN - 2455-8737
DOI - 10.23958/ijirms/vol03-i05/07
Subject(s) - microalbuminuria , medicine , hypertensive retinopathy , left ventricular hypertrophy , disease , hypertensive disease , nephropathy , hypertensive nephropathy , diabetes mellitus , retinopathy , cardiology , population , risk factor , kidney disease , diabetic nephropathy , blood pressure , endocrinology , kidney , environmental health
A total of 657 uncontrolled hypertensive patients (BP > 140/90 mm Hg in non-diabetics and BP >130/85 mm Hg in diabetic patients) were studied and followed for 12 months.
Out of which 374 (56.93%) were male and 283 (43.07%) were female. Retinopathy was observed in 91 (13.85%) cases and Left ventricular hypertrophy was seen in 91 (13.85%) patients. Out of 374 male patients 198 (52.94%) were smokers while 176 (47.06%) were non-smokers. Hypertension is an established risk factor for cardiovascular as well as renal disease. Prevalence of microalbuminuria in hypertensive patients suggests that screening for microalbuminuria is essential for intervention and prevention of further complications like end stage renal disease and cardiovascular disease. It is much more essential to screen for early nephropathy by testing microalbuminuria in hypertensive patients prevent or halt the earliest stages of damage by vigorous control of hypertension. Further studies in large scale population are required to further verification of microalbuminuria as a screening tool to prevent progression of cardiovascular and renal disease.